Company News

• 

  Time: 2024-3-29

  KangaBio will present preclinical data of IL-12 prodrug KGX101 at AACR 2024
• 

  Time: 2023-12-13

  KangaBio’s IL-12 Prodrug KGX101: dosing of the first patient was completed
• 

  Time: 2023-10-26

  KangaBio’s new generation IL-12 prodrug has been approved for IND application in the United States
• 

  Time: 2021-12-30

  KangaBio and QuaCell Biotechnology, Co., Ltd. sign a cooperation agreement
• 

  Time: 2021-10-16

  KangaBio and Sanyou Biopharmaceuticals Co., Ltd. sign a cooperation agreement
• 

  Time: 2021-08-01

  Shanghai KangaBio Opening Ceremony
• 

  Time: 2021-05-31

  KangaBio and Immune Targeting Inc. sign a cooperation agreement